In a patient experiencing fatigue and dysthymia while using Hailey‑FE (ethinyl estradiol 20 µg/levonorgestrel), would switching to a progestin‑only pill or to Nextstellis (drospirenone 3 mg/estetrol 15 mg) improve these symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Switching from Hailey FE to Progestin-Only or Nextstellis for Fatigue and Dysthymia

Switching to Nextstellis (estetrol 15 mg/drospirenone 3 mg) is the most evidence-based choice for improving fatigue and mood symptoms, as it has demonstrated significant improvements in emotional and physical premenstrual symptoms while maintaining contraceptive efficacy. 1

Why Nextstellis is the Preferred Switch

The most recent high-quality evidence from 2024 specifically evaluated Nextstellis (E4/DRSP) and found significant improvements in emotional symptoms. In a Phase 3 trial of 1,553 participants, those starting E4/DRSP (not switching from another hormonal method) experienced:

  • Significant reduction in Negative Affect scores (premenstrual: -2.5, menstrual: -2.7, both p<0.01) 1
  • Improvements in fatigue (>40% of participants reported reduced fatigue intensity) 1
  • Better mood stability with reductions in mood swings and irritability 1

This is particularly relevant since your patient is experiencing dysthymia (persistent low mood) and fatigue—symptoms directly addressed in this study.

Why Not Progestin-Only Pills

Progestin-only pills are less favorable for mood symptoms. The evidence shows:

  • Levonorgestrel (the progestin in Hailey FE) can cause "premenstrual-tension-like symptoms, including mood swings, bloating, fluid retention, and sleep disturbance" 2
  • Switching among progestational agents may decrease these symptoms, but guidelines note that side effects "are difficult to evaluate and vary with the progestational agent" 2
  • Case reports document development of depressive symptoms with progestin-only contraceptives 3

The Estrogen Component Matters

The type of estrogen is critical. Nextstellis contains estetrol (E4), a natural estrogen with unique properties:

  • E4 has "low impact on the liver, breast, and hemostasis parameters" while maintaining beneficial effects on mood and cardiovascular system 4
  • Lower thrombotic risk: E4/DRSP showed the lowest proportionality reporting rate for VTE (0.12) compared to ethinyl estradiol-based pills 5
  • The combination provides "predictable and regular bleeding profile" which may reduce cycle-related mood fluctuations 4

Your patient's current pill (Hailey FE) contains ethinyl estradiol 20 µg with levonorgestrel. The low estrogen dose may be contributing to mood symptoms, as estrogen has mood-stabilizing effects 2.

Practical Switching Algorithm

When switching from Hailey FE to Nextstellis:

  1. Start Nextstellis the day after finishing the last active pill of Hailey FE 6
  2. No backup contraception needed if switching directly 6
  3. Counsel that mood improvements typically manifest within 2-4 weeks, though full benefits may take 2-3 cycles 1
  4. Monitor for initial breakthrough bleeding (common in first cycle but improves) 6

Important Caveats

Screen for contraindications before switching:

  • Nextstellis is contraindicated with uncontrolled hypertension, renal impairment, hepatic dysfunction, or conditions predisposing to hyperkalemia 6
  • Monitor blood pressure at follow-up 6
  • The drospirenone component has antimineralocorticoid activity—check potassium if patient has risk factors 6

If severe depression rather than dysthymia: One small randomized trial found that adding drospirenone/ethinyl estradiol to antidepressants for premenstrual breakthrough depression showed no significant benefit over placebo 7. However, this was in women already on antidepressants with established major depression—a different clinical scenario than your patient's dysthymia.

Why This Recommendation

The 2024 Menstrual Distress Questionnaire data 1 represents the most recent, highest-quality evidence directly addressing your patient's symptoms. The study specifically evaluated emotional and physical symptoms including fatigue and mood, showing clear benefit in contraceptive starters. The safety profile of E4/DRSP is superior to traditional combined oral contraceptives 5, and the drospirenone component has established benefits for premenstrual symptoms 8.

Bottom line: Switch to Nextstellis rather than progestin-only pills for this patient with fatigue and dysthymia.

References

1
Research

Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2024

2
Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Related Questions

Can drospirenone‑ethinyl estradiol cause mood swings?
What is the difference between Loryna (drospirenone and ethinyl estradiol) and Sprintec (norgestimate and ethinyl estradiol)?
Does the combined oral contraceptive Finestride (ethinyl estradiol and norgestrel) cause mood swings or depression?
Can a patient use Nextstellis (drospirenone and estetrol) if they already have a Mirena (levonorgestrel) IUD (intrauterine device)?
Are Yaz (drospirenone and ethinyl estradiol) and Slynd (drospirenone) the same in terms of dosage?
What are the contraindications for brimonidine eye drops?
What are the pharmacologic effects, common adverse effects, dosing regimen, and contraindications of timolol maleate ophthalmic solution?
How can a basal ganglia stroke occur after coronary artery bypass grafting (CABG)?
Can you explain each prenatal ultrasound scan used in India—including ultrasound (USG), growth scan, anomaly scan, nuchal translucency (NT) scan, Doppler study, and biophysical profile (BPP)—and specify how to describe them to a pregnant mother and which trimester each is performed?
What are the names of the MAO‑inhibitor medications used for treatment‑resistant or atypical depression and certain anxiety disorders?
How much intracellular potassium is replenished by giving 100 milliequivalents of potassium chloride?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.